Subscribe To
Mink therapeutics to present data update from allogeneic inkt cells in solid tumors at sitc 2023
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharm...
September 27, 2023, 9:05 am
Strength seen in ionis pharmaceuticals (ions): can its 8.5% jump turn into more strength?
Ionis pharmaceuticals (IONS) saw its shares surge in the last session with trading volume being higher ...
September 27, 2023, 9:01 am
Crispr therapeutics to present at the society for immunotherapy of cancer (sitc) 38th annual meeting
ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharm...
September 27, 2023, 9:01 am
Amgen discloses more than $400 million stake in recent ipo neumora therapeutics
Amgen Inc.'s disclosure Wednesday of a large stake in Neumora Therapeutics Inc. indicates that the value of its investment in the bio...
September 27, 2023, 8:36 am
Valeo pharma secures $5m credit facility agreement with accord financial
Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) told investors it has entered into a $5 million credit facility with Accord Financial (TSX:ACD) which it said...
September 27, 2023, 8:33 am
Repligen (rgen) to acquire fluid management company metenova
Repligen (RGEN) is set to acquire a Swedish company, Metenova, which focuses on manufacturing magnetic mixers for ...
September 27, 2023, 8:16 am
3 things about johnson & johnson that smart investors know
J&J recently spun off its slowest-growing business -- consumer health. The healthcare giant aims to focus its resources in its ...
September 27, 2023, 5:30 am
Roquefort therapeutics preparing targets for clinic as eyes commercial deals
Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) is "on course with targets for clinical readiness" for one of its development programmes in the seco...
September 27, 2023, 3:32 am
Reviva pharmaceuticals: a binary event approaches with results from recover
Reviva pharmaceuticals is running a phase 3 study of brilaroxazine in schizophrenia called RECOVER, wit...
September 27, 2023, 2:48 am
Royalty pharma: the time has come
Royalty Pharma offers a unique exposure in the pharmaceutical sector thanks to a diversified portfolio ...
September 27, 2023, 2:15 am
Scpharmaceuticals: furoscix, charting a bright future with fda's nod for ckd
Positive FDA feedback for Furoscix's label expansion into chronic kidney disease signals the potential for significant market growth. Introduction of ...
September 27, 2023, 12:40 am
Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of ars pharmaceuticals, inc.
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of ARS ...
September 26, 2023, 8:40 pm
Protect pharmaceutical corp. ceo provides shareholder update
Istanbul, Turkey, Sept. 26, 2023 (GLOBE NEWSWIRE) — Protect pharmaceutical Corp. “OTC:(PRTT)” Pro...
September 26, 2023, 7:04 pm
Biogen inc. (biib) management presents at decentralized clinical trials in focus conference (transcript)
Biogen Inc. (NASDAQ:BIIB ) Decentralized Clinical Trials in Focus Conference September 26, 2023 10:00 AM ET Company Participants Stephanie Manson Brow...
September 26, 2023, 5:17 pm
Us judge overturns eli lilly's $176.5 million loss in teva patent case
Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva ...
September 26, 2023, 4:34 pm
Immunovant shares skyrocket after trial of its autoimmune drug beats expectations
Immunovant (IMVT) shares virtually doubled on Tuesday after the biopharmaceutical company reported posi...
September 26, 2023, 4:20 pm
Hillevax to participate in fireside chat at the 2023 cantor global healthcare conference
BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical...
September 26, 2023, 4:01 pm
Why intercept pharmaceuticals stock is skyrocketing today
The stock is exploding following an announcement that it's on track to be acquired. Alfasigma is poised to buy Intercept at a price of $19 per share....
September 26, 2023, 2:17 pm
Why is intercept pharmaceuticals (icpt) stock up 75% today?
Amid a rough day on Wall Street, Intercept pharmaceuticals (NASDAQ: ICPT ) represented a bright spot, w...
September 26, 2023, 2:11 pm
Intercept pharmaceuticals stock soars on alfasigma acquisition deal
Intercept pharmaceuticals (NASDAQ:ICPT) Inc shares surged 79% to $18.64 in late-morning trading on Tues...
September 26, 2023, 11:42 am